Study showed MiniMed™ 780G system achieved ADA-recommended time-in-range goals even on days users forgot to bolus

“These findings underscore the advanced capabilities of the MiniMed™ 780G system and its potential to ease the daily burden of diabetes care,” said Que Dallara, EVP and President of Medtronic Diabetes. “Our goal is to empower people with technology that adapts to their lives, even when things don’t go as planned.”